Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine + metoclopramide for reduction of gastric residual volume in mechanically ventilated ICU patients
IRCT201408104365N16Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of neostigmine and metoclopramide in feeding intolerance and gastroparesis, sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Gastric residual volume reduction. Started Mar 2014; status: completed.
02
Drugs
neostigminemetoclopramide
03
Conditions
feeding intolerancegastroparesis
Beyond the preview
Go deeper on IRCT201408104365N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201408104365N16.